marked variability monacolin levels commercial red yeast rice products buyer beware pubmed ncbi abstract background red yeast rice ryr widely dietary supplement millions patients alternative therapy hyperlipidemia num active compounds called monacolins inhibit hepatic cholesterol synthesis studies suggested formulations ryr effective safe lipid lowering monacolin levels standardized marketed products generally published labels evaluated monacolin levels num commercial ryr formulations tested citrinin mycotoxin nephrotoxic animals methods formulation ryr labeled num mg/capsule active product analyses monacolins citrinin performed august num june num high-performance liquid chromatography mass spectroscopy-mass spectroscopy detection laboratory analyses ryr products conducted consumerlab com white plains york results marked variability num ryr products total monacolins num num mg/capsule monacolin lovastatin num num mg/capsule monacolin ka num num mg/capsule products elevated levels citrinin conclusions found striking variability monacolin content num proprietary ryr products presence citrinin one-third formulations tested ryr potential alternative lipid-lowering agent findings suggest improved standardization ryr products product labeling occurs physicians cautious recommending ryr patients treatment hyperlipidemia primary secondary prevention cardiovascular disease 
